Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states

Cell and Tissue Research

Volumn 358, Issue 3, 2014, Pages 793-805

  Piacentini, Mauro ^a,b   D’Eletto, Manuela ^a   Farrace, Maria Grazia ^a   Rodolfo, Carlo ^a   Del Nonno, Franca ^b   Ippolito, Giuseppe ^b   Falasca, Laura ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Cell surface distribution; Endoplasmic reticulum; Human; Mitochondria; Nuclear localization; Transglutaminase 2

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; DOXORUBICIN; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANTIBODY LABELING; ARTICLE; CELL ACTIVITY; CELL NUCLEUS; CELL PROLIFERATION; CELL STRESS; CELL SURFACE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; HEART MUSCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE MUCOSA; KIDNEY CELL; MITOCHONDRION; NEUROBLASTOMA CELL; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; SARCOMA CELL; BIOLOGICAL MODEL; CELL FRACTIONATION; CELL MEMBRANE; DRUG EFFECTS; ENZYMOLOGY; EXTRACELLULAR SPACE; HEK293 CELL LINE; INTRACELLULAR SPACE; METABOLISM; MUSCLE FIBRIL; NEUROBLASTOMA; PATHOLOGY; PHYSIOLOGICAL STRESS; PROTEIN TRANSPORT; TUMOR CELL LINE; ULTRASTRUCTURE;

CELL LINE, TUMOR; CELL MEMBRANE; CELL NUCLEUS; DOXORUBICIN; EXTRACELLULAR SPACE; GTP-BINDING PROTEINS; HEK293 CELLS; HUMANS; INTESTINAL MUCOSA; INTRACELLULAR SPACE; MODELS, BIOLOGICAL; MYOFIBRILS; NEUROBLASTOMA; PROTEIN TRANSPORT; STRESS, PHYSIOLOGICAL; SUBCELLULAR FRACTIONS; TRANSGLUTAMINASES;

EID: 84919820125     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-014-1990-x     Document Type: Article

References (63)

1. Aeschlimann D, Thomazy V (2000) Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 41:1–27
2. Akker J van den, Weert A van, Afink G, Bakker EN, Pol E van der, Böing AN, Nieuwland R, VanBavel E (2012) Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation. Amino Acids 42:961–973
3. Bergamini CM, Collighan RJ, Wang Z, Griffin M (2011) Structure and regulation of type 2 transglutaminase in relation to its physiological functions and pathological roles. Adv Enzymol Relat Areas Mol Biol 78:1–46
4. Bersten AM, Ahkong QF, Hallinan T, Nelson SJ, Lucy JA (1983) Inhibition of the formation of myotubes in vitro by inhibitors of transglutaminase. Biochim Biophys Acta 762:429–436
5. Biagi F, Campanella J, Laforenza U, Gastaldi G, Tritto S, Grazioli M, Villanacci V, Corazza GR (2006) Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent. Dig Liver Dis 38:652–658
6. Caccamo D, Currò M, Ferlazzo N, Condello S, Ientile R (2012) Monitoring of transglutaminase 2 under different oxidative stress conditions. Amino Acids 4:1037–1043
7. Chen SH, Lin CY, Lee LT, Chang GD, Lee PP, Hung CC, Kao WT, Tsai PH, Schally AV, Hwang JJ, Lee MT (2010) Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells. Anticancer Res 30:4177–4186
8. Choi CM, Jang SJ, Park SY, Choi YB, Jeong JH, Kim DS, Kim HK, Park KS, Nam BH, Kim HR, Korean Thoracic Oncology Research Group (KTORG), Kim SY, Hong KM (2011) Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer. Mol Cancer 10:119
9. Cohen I, Poręba E, Kamieniarz K, Schneider R (2011) Histone modifiers in cancer: friends or foes? Genes Cancer 2:631–647
10. Collighan RJ, Griffin M (2009) Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids 36:659–670
11. Del Nonno F, Pisani G, Visca P, Signore F, Grillo LR, Baiocchini A, Garbuglia AR, Sepe S, Piacentini M, Falasca L (2011) Role and predictive strength of transglutaminase type 2 expression in premalignant lesions of the cervix. Mod Pathol 24:855–865
12. D'Eletto M, Farrace MG, Falasca L, Reali V, Oliverio S, Melino G, Griffin M, Fimia GM, Piacentini M (2009) Transglutaminase 2 is involved in autophagosome maturation. Autophagy 5:1145–1154
13. D'Eletto M, Farrace MG, Rossin F, Strappazzon F, Giacomo GD, Cecconi F, Melino G, Sepe S, Moreno S, Fimia GM, Falasca L, Nardacci R, Piacentini M (2012) Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins. Cell Death Differ 19:1228–1238
14. Di Sabatino A, Vanoli A, Giuffrida P, Luinetti O, Solcia E, Corazza GR (2012) The function of tissue transglutaminase in celiac disease. Autoimmun Rev 11:746–753
15. Esposito C, Caputo I (2005) Mammalian transglutaminases: identification of substrates as a key to physiological function and physiopathological relevance. FEBS J 272:615–631
16. Facchiano F, Facchiano A, Facchiano AM (2006) The role of transglutaminase-2 and its substrates in human diseases. Front Biosci 11:1758–1773
17. Falasca L, Iadevaia V, Ciccosanti F, Melino G, Serafino A, Piacentini M (2005) Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment. J Immunol 174:7330–7340
18. Falasca L, Farrace MG, Rinaldi A, Tuosto L, Melino G, Piacentini M (2008) Transglutaminase Type II is involved in the pathogenesis of endotoxic shock. J Immunol 180:2616–2624
19. Fesus L, Piacentini M (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27:534–539
20. Fésüs L, Szondy Z (2005) Transglutaminase 2 in the balance of cell death and survival. FEBS Lett 579:3297–3302
21. Fimia GM, Piacentini M (2010) Regulation of autophagy in mammals and its interplay with apoptosis. Cell Mol Life Sci 67:1581–1588
22. Gard DL, Lazarides E (1979) Specific fluorescent labelling of chicken myofibril Z-line proteins catalyzed by guinea pig liver transglutaminase. J Cell Biol 81:336–347
23. Gobbi M, Frittoli E, Mennini T (1996) Role of transglutaminase in [3H]5-HT release from synaptosomes and in the inhibitory effect of tetanus toxin. Neurochem Int 29:129–134
24. Gundemir S, Colak G, Tucholski J, Johnson GV (2012) Transglutaminase 2: a molecular Swiss army knife. Biochim Biophys Acta 1823:406–419
25. Herman JF, Mangala LS, Mehta K (2006) Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene 25:3049–3058
26. Ientile R, Caccamo D, Griffin M (2007) Tissue transglutaminase and the stress response. Amino Acids 33:385–394
27. Jones RA, Nicholas B, Mian S, Davies PJ, Griffin M (1997) Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J Cell Sci 110:2461–2472
28. Jeong EM, Kim CW, Cho SY, Jang GY, Shin DM, Jeon JH, Kim IG (2009) Degradation of transglutaminase 2 by calcium-mediated ubiquitination responding to high oxidative stress. FEBS Lett 583:648–654
29. Kim JH, Nam KH, Kwon OS, Kim IG, Bustin M, Choy HE, Park SC (2002) Histone cross-linking by transglutaminase. Biochem Biophys Res Commun 293:1453–1457
30. Kim Y, Park YW, Lee YS, Jeoung D (2008) Hyaluronic acid induces transglutaminase II to enhance cell motility; role of Rac1 and FAK in the induction of transglutaminase II. Biotechnol Lett 30:31–39
31. Klöck C, Diraimondo TR, Khosla C (2012) Role of transglutaminase 2 in celiac disease pathogenesis. Semin Immunopathol 34:513–522
32. Korner G, Schneider DE, Purdon MA, Bjornsson TD (1989) Bovine aortic endothelial cell transglutaminase enzyme characterization and regulation of activity. Biochem J 262:633–641
33. Lesort M, Attanavanich K, Zhang J, Johnson GV (1998) Distinct nuclear localization and activity of tissue transglutaminase. Biol Chem 273:11991–11994
34. Lin CY, Tsai PH, Kandaswami CC, Chang GD, Cheng CH, Huang CJ, Lee PP, Hwang JJ, Lee MT (2011) Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells. Mol Cancer 10:87–100
35. Lorand L, Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4:140–156
36. Malorni W, Farrace MG, Matarrese P, Tinari A, Ciarlo L, Mousavi-Shafaei P, D'Eletto M, Di Giacomo G, Melino G, Palmieri L, Rodolfo C, Piacentini M (2009) The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis. Cell Death Differ 16:1480–1492
37. Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kunnumakkara AB, Kumar R, Aggarwal BB, Mehta K (2006) Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway. Cancer Res 66:8788–8795
38. Mehta K, Kumar A, Kim HI (2010) Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer. Biochem Pharmacol 80:1921–1929
39. Mishra S, Saleh A, Espino PS, Davie JR, Murphy LJ (2006) Phosphorylation of histones by tissue transglutaminase. J Biol Chem 281:5532–5538
40. Miyoshi N, Ishii H, Mimori K, Tanaka F, Hitora T, Tei M, Sekimoto M, Doki Y, Mori M (2010) TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer. Ann Surg Oncol 17:967–972
41. Nowak SJ, Corces VG (2004) Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 20:214–220
42. Oh K, Ko E, Kim HS, Park AK, Moon HG, Noh DY, Lee DS (2011) Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells. Breast Cancer Res 13:R96
43. Park D, Choi SS, Ha KS (2010) Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino Acids 39:619–631
44. Park MK, Lee HJ, Shin J, Noh M, Kim SY, Lee CH (2011) Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells. Biochim Biophys Acta 1811:1021–1029
45. Pastuszko A, Wilson DF, Erecinska M (1986) A role for transglutaminase in neurotransmitter release by rat brain synaptosomes. J Neurochem 46:499–508
46. Piacentini M, Farrace MG, Piredda L, Matarrese P, Ciccosanti F, Falasca L, Rodolfo C, Giammarioli AM, Verderio E, Griffin M, Malorni W (2002) Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress. J Neurochem 81:1061–1072
47. Piacentini M, D'Eletto M, Falasca L, Farrace MG, Rodolfo C (2011) Transglutaminase 2 at the crossroads between cell death and survival. Adv Enzymol Relat Areas Mol Biol 78:197–246
48. Pyle WG, Solaro RJ (2004) At the crossroads of myocardial signaling: the role of Z-discs in intracellular signaling and cardiac function. Circ Res 94:296–305
49. Rani MR, Foster GR, Leung S, Leaman D, Stark GR, Ransohoff RM (1996) Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J Biol Chem 271:22878–22884
50. Rodolfo C, Mormone E, Matarrese P, Ciccosanti F, Farrace MG, Garofano E, Piredda L, Fimia GM, Malorni W, Piacentini M (2004) Tissue transglutaminase is a multifunctional BH3-only protein. J Biol Chem 279:54783–54792
51. Rossin F, D’Eletto M, Macdonald D, Farrace MG, Piacentini M (2012) TG2 transamidating activity acts as a reostat controlling the interplay between apoptosis and autophagy. Amino Acids 42:1793–1802
52. Sane DC, Kontos JL, Greenberg CS (2007) Roles of transglutaminases in cardiac and vascular diseases. Front Biosci 12:2530–2545
53. Santhanam L, Berkowitz DE, Belkin AM (2011) Nitric oxide regulates non-classical secretion of tissue transglutaminase. Commun Integr Biol 5:584–586
54. Song Y, Kirkpatrick LL, Schilling AB, Helseth DL, Chabot N, Keillor JW, Johnson GV, Brady ST (2013) Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules. Neuron 78:109–123
55. Spurlin TA, Bhadriraju K, Chung KH, Tona A, Plant AL (2009) The treatment of collagen fibrils by tissue transglutaminase to promote vascular smooth muscle cell contractile signaling. Biomaterials 30:5486–5496
56. Szegezdi E, Macdonald DC, Ni Chonghaile T, Gupta S, Samali A (2009) Bcl-2 family on guard at the ER. Am J Physiol Cell Physiol 296:C941–C953
57. Tatsukawa H, Fukaya Y, Frampton G, Martinez-Fuentes A, Suzuki K, Kuo TF, Nagatsuma K, Shimokado K, Okuno M, Wu J, Iismaa S, Matsuura T, Tsukamoto H, Zern MA, Graham RM, Kojima S (2009) Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1. Gastroenterology 136:1783–1795
58. Verderio EA, Telci D, Okoye A, Melino G, Griffin M (2003) A novel RGD-independent cel adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis. J Biol Chem 278:42604–42614
59. Verhaar R, Drukarch B, Bol JG, Jongenelen CA, Musters RJ, Wilhelmus MM (2012) Increase in endoplasmic reticulum-associated tissue transglutaminase and enzymatic activation in a cellular model of Parkinson's disease. Neurobiol Dis 45:839–850
60. Wang Z, Griffin M (2012) TG2, a novel extracellular protein with multiple functions. Amino Acids 42:939–949
61. Xu D, Bai J, Duan Q, Costa M, Dai W (2009) Covalent modifications of histones during mitosis and meiosis. Cell Cycle 8:3688–3694
62. Zemskov EA, Janiak A, Hang J, Waghray A, Belkin AM (2006) The role of tissue transglutaminase in cell-matrix interactions. Front Biosci 11:1057–1076
63. Zemskov EA, Mikhailenko I, Hsia R-C, Zaritskaya L, Belkin AM (2011) Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes. PLoS ONE 6:e19414